Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-life efficacy of guselkumab in patients with early psoriatic arthritis.
Pantano I, Mauro D, Romano F, Gambardella A, Valenti M, Simone D, Iacono D, Costanzo A, Argenziano G, Ciccia F. Pantano I, et al. Among authors: gambardella a. Rheumatology (Oxford). 2022 Mar 2;61(3):1217-1221. doi: 10.1093/rheumatology/keab509. Rheumatology (Oxford). 2022. PMID: 34152379
Brodalumab for the treatment of moderate-to-severe plaque-type psoriasis: a real-life, retrospective 24-week experience.
Fargnoli MC, Esposito M, Dapavo P, Parodi A, Rossi M, Tiberio R, Dastoli S, Offidani AM, Argenziano G, Gisondi P, Lo Schiavo A, Loconsole F, Pella P, Bardazzi F, Cusano F, Gattoni M, Nacca M, Cannavò SP, Pellegrini C, Costanzo A; BRILLIANT Working Group. Fargnoli MC, et al. J Eur Acad Dermatol Venereol. 2021 Mar;35(3):693-700. doi: 10.1111/jdv.16931. Epub 2020 Oct 13. J Eur Acad Dermatol Venereol. 2021. PMID: 32916767
Successful treatment of Pityriasis rubra pilaris with brodalumab.
De Rosa A, Gambardella A, Licata G, Alfano R, Argenziano G. De Rosa A, et al. Among authors: gambardella a. Australas J Dermatol. 2020 May;61(2):e249-e251. doi: 10.1111/ajd.13215. Epub 2019 Dec 18. Australas J Dermatol. 2020. PMID: 31851372 No abstract available.
SAPHO syndrome successful treated with tildrakizumab.
Licata G, Gambardella A, Calabrese G, Alfano R, Argenziano G. Licata G, et al. Among authors: gambardella a. Dermatol Ther. 2021 Jan;34(1):e14758. doi: 10.1111/dth.14758. Epub 2021 Jan 11. Dermatol Ther. 2021. PMID: 33405331 No abstract available.
A case of refractory palmoplantar psoriasis treated with tildrakizumab.
Gambardella A, Licata G, Tancredi V, Calabrese G, DE Rosa A, Alfano R, Argenziano G. Gambardella A, et al. Ital J Dermatol Venerol. 2022 Aug;157(4):379-380. doi: 10.23736/S2784-8671.21.07148-6. Ital J Dermatol Venerol. 2022. PMID: 35916185 No abstract available.
Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study.
Megna M, Di Costanzo L, Argenziano G, Balato A, Colasanti P, Cusano F, Galluccio AG, Gambardella A, Lembo S, Mozzillo R, Scotto Di Luzio G, Fabbrocini G, Balato N. Megna M, et al. Among authors: gambardella a. Expert Opin Biol Ther. 2019 Aug;19(8):855-861. doi: 10.1080/14712598.2019.1622678. Epub 2019 May 29. Expert Opin Biol Ther. 2019. PMID: 31140882
Brodalumab treatment in psoriasis patients with severe renal failure.
Ribero S, Conti V, Gambardella A, DE Rosa AB, Dapavo P, Argenziano G. Ribero S, et al. Among authors: gambardella a. Ital J Dermatol Venerol. 2021 Jun;156(3):406-408. doi: 10.23736/S2784-8671.20.06719-X. Epub 2020 Nov 23. Ital J Dermatol Venerol. 2021. PMID: 33228335 No abstract available.
718 results